Enigma Biomedical USA, Inc. (EB USA) today announced that it has selected two (2) four-repeat tau (4R Tau) protein PET imaging biomarkers to advance into Phase 1 (Ph1) studies. Previously, EB USA ...

We believe our 4R Tau PET imaging biomarkers from AbbVie have ... including metabolite formation and the dynamics of tracer uptake, retention and clearance. A final candidate for future ...

When we last looked at Lantheus in May, its stock was trading just under $80 a share. As a reminder, Lantheus Holdings, Inc.

TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...

Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug ...

As of 2:26:36 PM EDT. Market Open. AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update Landmark exclusive option and license deal with Takeda for ACI-24.060 with $ ...

After hours: 25 March at 5:21:35 pm GMT-4 Loading Chart for LNTH ...

After hours: March 21 at 6:15:25 p.m. EDT Loading Chart for LNTH ...